Evidence map›Paper›PMID 33492932›Full record

ArticleACS infectious diseases2021

Areas of Metabolomic Exploration for Helminth Infections.

Jeffrey D Whitman, Judy A Sakanari, Makedonka Mitreva

Open access · hybridAbstract read
In one paragraph

Article in ACS infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Anisakiasis: A Decade of Molecular and Diagnostic Advancements (2015-2026).International journal of molecular sciences · 2026
    Review
  3. Co-Infection Dynamics ofInternational journal of molecular sciences · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Metabolite profiling ofFrontiers in cellular and infection microbiology · 2023
    Article
  12. Article
  13. Review
  14. Review
  15. Parasite OMICS, the grand challenges ahead.Frontiers in parasitology · 2022
    Article
  16. Detangling the Crosstalk BetweenFrontiers in cellular and infection microbiology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jeffrey D WhitmanDepartment of Laboratory Medicine, University of California, San Francisco, San Francisco, California 94110, United States.ORCID 0000-0002-3502-5799
Judy A SakanariDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94158, United States.ORCID 0000-0003-3895-2982
Makedonka MitrevaDepartment of Medicine, Washington University School of Medicine, St. Louis, Missouri 63130, United States.
University of California, San Francisco · USWashington University in St. Louis · US

Funding

EVOLUTION OF THE NEMATODE INTESTINE, A KEY HOST INTERFACER01GM097435 · NIGMS · WASHINGTON UNIVERSITY · PI MITREVA, MAKEDONKA · 2011 to 2019
$2.1M
Host-parasite lipid metabolism in Trypanosoma cruzi-infected cardiac myocytesK38HL154203 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WHITMAN, JEFFREY DOMINICK · 2020 to 2021
$227k
NHLBI NIH HHS K38 HL154203NIGMS NIH HHS R01 GM097435
6 · The paper itself

Abstract

Helminths represent a diverse category of parasitic organisms that can thrive within a host for years, if not decades, in the absence of treatment. As such, they must establish mechanisms to subsist off their hosts, evade the immune system, and develop a niche among the other cohabiting microbial communities. The complex interplay of biologically small molecules (collectively known as the metabolome) derived from, utilized by, or in response to the presence of helminths within a host is an emerging field of study. In this Perspective, we briefly summarize the current existing literature, categorize key host-pathogen-microbiome interfaces that could be studied in the context of the metabolome, and provide background on mass spectrometry-based metabolomic methodology. Overall, we hope to provide a comprehensive guide for utilizing metabolomics in the context of helminthic disease.

Indexed as

HelminthiasisHelminthsParasitesAnimalsMetabolomeMetabolomicshelminthsimmunologymass spectrometrymetabolomicsmicrobiomeparasites

Identifiers

PMID33492932
PMCPMC7887738
OpenAlexW3121319483

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.